Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01702246 · ClinicalTrials.gov registry record · Phase 1
Effect of Simvastatin Treatment on Vaso-occlusive Pain in Sickle Cell Disease
A Phase 1 study, sponsored by UCSF Benioff Children's Hospital Oakland.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT01702246: Completed Phase 1 study, sponsored by UCSF Benioff Children's Hospital Oakland.
NCT01702246 is a Phase 1 study that has completed, run by UCSF Benioff Children's Hospital Oakland. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01702246, a Phase 1 study, has completed, sponsored by UCSF Benioff Children's Hospital Oakland.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether simvastatin is effective in reducing the frequency and intensity of vaso-occlusive pain episodes in patients with sickle cell disease.
Interventions
- DRUG Simvastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2012-02 |
| Est. Completion | 2015-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01702246
The ClinicalTrials.gov registry entry for NCT01702246 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UCSF Benioff Children's Hospital Oakland, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Simvastatin is the first listed.
NCT01702246 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01702246 about?
NCT01702246 is a clinical study titled "Effect of Simvastatin Treatment on Vaso-occlusive Pain in Sickle Cell Disease". The purpose of this study is to determine whether simvastatin is effective in reducing the frequency and intensity of vaso-occlusive pain episodes in patients with sickle cell disease.
What is the current status of trial NCT01702246?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2012-02. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01702246?
The interventions under investigation include: Simvastatin (DRUG).
Who is sponsoring clinical trial NCT01702246?
This trial is sponsored by UCSF Benioff Children's Hospital Oakland, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.